Calls Now Open
2027 Scholar-Innovator and ADDF-Harrington
Neuroscience
Development of Novel CCR3 Chemokine Receptor Peptide and Small Molecule Functionally Selective Biased Antagonists to Treat Neuroinflammation in Alzheimer's Disease
2025 ADDF-Harrington Scholar
Full profile coming soon.